Applied Dna Scns (APDN) Stock Price, Quote & News

Company Profile

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity sy...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 631 240 8800

Fax: 631 240 8900

Website: www.adnas.com

Address:

50 Health Sciences Drive, Stony Brook, United States

Firedolphin21 Sep. 7 at 3:27 PM

$OPEN $IVF $APDN $SMX SORRY HAVENT BEEN POSTING MUCH BEEN ENJOYING THE FRUITS OF MY HARD WORK AMD DONT GET GOOD COVERAGE ON THE BOAT GOD IS GOOD FEELING SO BLESSED LOADED HEAVY AF IN IVF AND APDN DO RESEARCH AND YOU WILL BE AS WELL.. IN SMX FOR NEXT RUN HARD WORK WORKS..RAW ACTION ..DO SOMETHING WITH YOUR LIFE TO BLESS OTHERS..

0 · Reply

InvincibleX Sep. 7 at 10:46 AM

$APDN It's a little bit closer to $1. Another RS will be coming soon.

0 · Reply

Bubbasoup09 Sep. 6 at 12:12 PM

$APDN been expecting a move into the low $2S. I guess it’s better to rip the band-aid off versus bleeding off for 2 more weeks. There were ~85k series B remaining, so could take it as low as they wanted. Yesterday’s volume should have been enough to clear these. I suspect a good amount was panic selling/ SLs though. Look for an update of O/S to ~1.5mil, confirmation Short interest went from 13% a couple week ago to 5% now. 🤔 Yes, as pointed out below. 3mil+ Series A @ $5.13. You think the 2 largest institutional owners are leaving $15MIL on the table? Are they going to squeeze more out of short position? 🤷🏻‍♂️ Monday will be SSR, but probably still goes down as people continue the panic selling. Is the company and stock shit? Yes 1000% Can this go lower? Yes 100% Do they let the value of holdings and A warrants goto zero? 🤔

2 · Reply

CometaMan Sep. 6 at 5:39 AM

$APDN it is ready for a nice run into the 5 or 6sexs

0 · Reply

stocks4growth Sep. 6 at 4:23 AM

$APDN what happend here?? Didn't check yesterday...i'm sitting on an avg. of 25 😑

1 · Reply

VP_BagHolderInc Sep. 5 at 8:47 PM

$APDN 🚀🚀🚀🚀

0 · Reply

boomshiva Sep. 5 at 8:46 PM

$APDN Yikes

0 · Reply

SirBank Sep. 5 at 8:09 PM

$ADAP $APDN did I honestly just get fucked this hard LMFAO since Taco came into fruition the market has been volatile as fuck.

0 · Reply

tradeswellwithothers Sep. 5 at 7:51 PM

$APDN wouldn’t be surprised to see red to green today. I remember $MLGO did something very similar and then squeezed like 1000% in the coming sessions

0 · Reply

BennyBjammin Sep. 5 at 7:48 PM

$APDN I must say, it does look promising as long as this trendline doesn't break.

0 · Reply

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Jul 24, 2025, 9:00 AM EDT - 6 weeks ago

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Jul 7, 2025, 9:00 AM EDT - 2 months ago

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Jun 30, 2025, 9:00 AM EDT - 2 months ago

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Jun 17, 2025, 4:10 PM EDT - 2 months ago

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Jun 16, 2025, 9:00 AM EDT - 2 months ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

May 29, 2025, 8:00 AM EDT - 3 months ago

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

May 15, 2025, 4:05 PM EDT - 4 months ago

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

May 14, 2025, 11:30 AM EDT - 4 months ago

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

Apr 21, 2025, 9:00 AM EDT - 4 months ago

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Apr 8, 2025, 9:00 AM EDT - 5 months ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Apr 1, 2025, 9:45 AM EDT - 5 months ago

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Mar 26, 2025, 9:00 AM EDT - 5 months ago

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

Mar 12, 2025, 8:00 AM EDT - 6 months ago

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

Feb 14, 2025, 2:10 PM EST - 7 months ago

Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript

Feb 13, 2025, 4:03 PM EST - 7 months ago

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

Feb 12, 2025, 12:00 PM EST - 7 months ago

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Feb 11, 2025, 8:30 AM EST - 7 months ago

Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

Jan 10, 2025, 9:00 AM EST - 8 months ago

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Jan 8, 2025, 4:30 PM EST - 8 months ago

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Dec 18, 2024, 9:00 AM EST - 9 months ago

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Dec 17, 2024, 4:05 PM EST - 9 months ago

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Dec 16, 2024, 10:00 AM EST - 9 months ago

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Oct 30, 2024, 7:15 AM EDT - 11 months ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 15, 2024, 10:30 AM EDT - 11 months ago

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Sep 17, 2024, 9:15 AM EDT - 1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Sep 17, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Sep 11, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Sep 4, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Aug 23, 2024, 1:19 PM EDT - 1 year ago

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 19, 2024, 3:25 PM EDT - 1 year ago

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 11, 2024, 12:29 PM EDT - 1 year ago

Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

Jul 29, 2024, 11:57 AM EDT - 1 year ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:10 AM EDT - 1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

Jul 18, 2024, 10:00 AM EDT - 1 year ago

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

Jun 20, 2024, 9:15 AM EDT - 1 year ago

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

MRVI

Jun 18, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Jun 13, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

Jun 10, 2024, 1:14 PM EDT - 1 year ago

Time to Play 5 Top-Ranked Stocks With Rising P/E?

AMC HCAT XGN YOU

Jun 5, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform

$Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML$

May 13, 2024, 8:55 AM EDT - 1 year ago

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

May 10, 2024, 4:05 PM EDT - 1 year ago

Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results

Apr 25, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program

Apr 22, 2024, 4:05 PM EDT - 1 year ago

Applied DNA Announces 1-For-20 Reverse Stock Split

Mar 18, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start

Mar 14, 2024, 10:00 AM EDT - 1 year ago

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress

Firedolphin21 Sep. 7 at 3:27 PM

0 · Reply

InvincibleX Sep. 7 at 10:46 AM

$APDN It's a little bit closer to $1. Another RS will be coming soon.

0 · Reply

Bubbasoup09 Sep. 6 at 12:12 PM

2 · Reply

CometaMan Sep. 6 at 5:39 AM

$APDN it is ready for a nice run into the 5 or 6sexs

0 · Reply

stocks4growth Sep. 6 at 4:23 AM

$APDN what happend here?? Didn't check yesterday...i'm sitting on an avg. of 25 😑

1 · Reply

VP_BagHolderInc Sep. 5 at 8:47 PM

$APDN 🚀🚀🚀🚀

0 · Reply

boomshiva Sep. 5 at 8:46 PM

$APDN Yikes

0 · Reply

SirBank Sep. 5 at 8:09 PM

$ADAP $APDN did I honestly just get fucked this hard LMFAO since Taco came into fruition the market has been volatile as fuck.

0 · Reply

tradeswellwithothers Sep. 5 at 7:51 PM

$APDN wouldn’t be surprised to see red to green today. I remember $MLGO did something very similar and then squeezed like 1000% in the coming sessions

0 · Reply

BennyBjammin Sep. 5 at 7:48 PM

$APDN I must say, it does look promising as long as this trendline doesn't break.

0 · Reply

MadHatterTrades74 Sep. 5 at 7:47 PM

$APDN Just throwing it out here, the company has 3.2 million outstanding warrants with an exercise price of $5.13. So if this ever runs up with a pump I’d be hopping out before that $5.13 target price.

0 · Reply

KoreanVenezuelan1992 Sep. 5 at 7:41 PM

$APDN rsi 14, added 4,000 shares. Low float, might go parabolic

0 · Reply

NovaFoster Sep. 5 at 7:40 PM

$APDN Big names showing up. Low float. Lets rip.

0 · Reply

YouVSYou Sep. 5 at 7:38 PM

$APDN that was cute

1 · Reply

StockAuthority Sep. 5 at 7:35 PM

$APDN added dip

0 · Reply

tradeswellwithothers Sep. 5 at 7:34 PM

$APDN that’s the dip I’ve been waiting weeks for - in at 2.27 avg LFG

0 · Reply

Najoua233902 Sep. 5 at 7:32 PM

$APDN either MM buying cheap shares for a pump or some bad news that I don’t see interesting set up could be fun AH

0 · Reply

NovaFoster Sep. 5 at 7:32 PM

$APDN Oversold IMO. I added heavy.

0 · Reply

BennyBjammin Sep. 5 at 7:29 PM

$APDN "I don't understand the dip" Chart: 1 share once equaled 21.6 Trillion dollars when dilution is factored in. We got a MULN here... sorry BINI. $ wash for Washington. How could the SEC look at this chart and go... yeah, that's normal.

0 · Reply

Najoua233902 Sep. 5 at 7:28 PM

$APDN just entered

0 · Reply

pi828 Sep. 5 at 7:27 PM

$APDN do you mean @Firedolphin21 ?

1 · Reply

Najoua233902 Sep. 5 at 7:27 PM

$APDN no one knows hmmm Friday is like talking to yourself and trading alone in this planet

0 · Reply

Market Cap	7.25M
Revenue (ttm)	3.43M
Net Income (ttm)	-6.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-203.79%
Debt to Equity Ratio	0.00

Volume	593,352
Avg Vol	3,662,574
Day's Range	N/A - N/A
Shares Out	55.19M
Stochastic %K	2%
Beta	0.43
Analysts	Hold
Price Target	$1.50